help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on June 26, 2008
Endocrinology, doi:10.1210/en.2007-1211
A more recent version of this article appeared on October 1, 2008
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
149/10/5199    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Matthews, L. C
Right arrow Articles by Westwood, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Matthews, L. C
Right arrow Articles by Westwood, M.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Substance via MeSH

Submitted on August 31, 2007
Accepted on June 13, 2008

Modulation of caveolin-1 expression can effect signalling through the PI-3K/Akt pathway and cellular proliferation in response to IGF-I

Laura C Matthews, Michael J Taggart, and Melissa Westwood*

Endocrine Sciences, Maternal and Fetal Health Research Group, University of Manchester, Manchester, M13 9PT, UK

* To whom correspondence should be addressed. E-mail: melissa.westwood{at}manchester.ac.uk.

The insulin-like growth factors (IGFs) mediate their effects on cell function through the type 1 IGF receptor (IGFIR) and numerous intracellular signalling molecules including the PI-3K/Akt pathway. The IGFIR also binds to the caveolae protein caveolin-1 but the impact of caveolae on IGF/PI3K/Akt signalling remains controversial. We have examined the effect of complete (knockout) and partial (knockdown) caveolin-1 deficiency on cellular IGF effects mediated via the PI3K/Akt pathway.

Under basal conditions, caveolin-1 deficient (MF(-/-)) mouse embryonic fibroblast cells incorporated significantly more 3H-thymidine than wildtype (MF(+/+)) cells, however shRNA-mediated knockdown of caveolin-1 (80% reduction) in 3T3L1 fibroblasts had no affect on basal proliferation. Interestingly, IGF-I induced proliferation was similar in MF(-/-) and MF(+/+) cells whilst caveolin-1 knockdown promoted a hyperproliferative response to IGF-I (pkDCav3T3L1(80) 12.4±0.4-fold; pkDShuffle3T3L1 4.3±0.2-fold induction, p<0.01).

Immunoblot analysis showed that caveolin-1 knockdown had no affect on Akt expression or activation. However in MF(-/-) cells, IGF-I-stimulated phosphorylation of Akt was reduced despite upregulated Akt levels. Further investigation demonstrated that caveolin knockout upregulated Akt-2 and Akt-3 isoform expression but Akt-1 expression was downregulated; interestingly, co-immunoprecipitation studies revealed Akt-1 as the predominant isoform to be phosphorylated in response to IGF-I.

In summary, caveolin-1 deficiency promotes a hyperproliferative response to IGF-I that is unrelated to Akt expression/activation. However, cells which lack caveolin are able to respond appropriately to IGF-1 through compensatory changes in Akt isoform expression. These data posit caveolin-1 as a component of the IGF/PI3K/Akt signalling modulus regulating cellular proliferation with implications for diseases, including cancers, which have altered caveolin expression.


Key words: Akt • IGF-I • caveolae • proliferation • apoptosis







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2008 by The Endocrine Society